Eagle Genomics Ltd. announced that it will raise funding on October 31, 2022.
On the same date, the company announced that it has raised $20 million led new investor, abrdn plc in its first tranche closing. The transaction also included participation from returning investors, Environmental Technologies Fund LP, a fund managed by ETF Partners LLP and consortium led by Granpool Innovative Investments. The company expects to receive additional funding of $10 million.